ARISE: pAdsevonil in drug-ResIStant Epilepsy. A randomized, double-blind, placebo-controlled, dose finding study to evaluate the efficacy and safety of Padsevonil as adjunctive treatment of focal-onset seizures in adult subjects with drug resistant epilepsy.

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Kwan, Patrick (Chief Investigator (CI))
  • D'Souza, Wendyl Jude (Chief Investigator (CI))
  • Berkovic, Samuel F. (Chief Investigator (CI))
  • Wijayath, Manori (Chief Investigator (CI))
  • Carney, Patrick (Chief Investigator (CI))
  • Lawn, Nicholas D. (Chief Investigator (CI))
  • Seneviratne, Udaya (Chief Investigator (CI))
  • Reutens, David Charles (Chief Investigator (CI))
  • Zentner, Christian (Chief Investigator (CI))
  • Frasca, Joseph (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date11/12/18 → 11/12/19